|
medpundit |
||
 |
 |
|
Friday, February 04, 2005Sanz and his team searched the World Health Organization (WHO) database on adverse drug reactions for convulsions and withdrawal symptoms in newborns associated with the use of SSRIs in 72 countries. Ninety-three cases had been reported by November 2003, which they said suggested a causal relationship. 'Nearly two-thirds of reported cases of suspected SSRI-induced neonatal withdrawal syndrome were associated with paroxetine,' Sanz said. All of cases reported in the study recovered after a few hours or a day. Vladislav Ruchkin and Andres Martin, of Yale University School of Medicine in the United States, said the research raises the question of how concerned we should be about exposing the youngest patients to SSRIs. 'It remains to be seen whether ... (the) report ultimately reflects a minor problem for a particular antidepressant, or further evidence of a larger set of serious problems for SSRI use in young people,' they said in a commentary. In the meantime, they suggested doctors use non-drug therapies and review prescription thresholds, particularly during pregnancy. OOPS: That should be "withdrawal." posted by Sydney on 2/04/2005 07:59:00 AM 0 comments 0 Comments: |
|
